AU2002302851A1 - Atopy - Google Patents

Atopy

Info

Publication number
AU2002302851A1
AU2002302851A1 AU2002302851A AU2002302851A AU2002302851A1 AU 2002302851 A1 AU2002302851 A1 AU 2002302851A1 AU 2002302851 A AU2002302851 A AU 2002302851A AU 2002302851 A AU2002302851 A AU 2002302851A AU 2002302851 A1 AU2002302851 A1 AU 2002302851A1
Authority
AU
Australia
Prior art keywords
atopy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002302851A
Other languages
English (en)
Inventor
William Cookson
Miriam Moffatt
Jon Tinsley
Youming Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0115213A external-priority patent/GB0115213D0/en
Priority claimed from GB0115212A external-priority patent/GB0115212D0/en
Priority claimed from GBGB0115211.5A external-priority patent/GB0115211D0/en
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of AU2002302851A1 publication Critical patent/AU2002302851A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2002302851A 2001-06-21 2002-06-21 Atopy Abandoned AU2002302851A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0115213A GB0115213D0 (en) 2001-06-21 2001-06-21 SNP markers for atopy
GB0115213.1 2001-06-21
GB0115212.3 2001-06-21
GB0115212A GB0115212D0 (en) 2001-06-21 2001-06-21 Atopy
GBGB0115211.5A GB0115211D0 (en) 2001-06-21 2001-06-21 B-cell chronic lymphocytic leukemia
GB0115211.5 2001-06-21
PCT/GB2002/002859 WO2003000727A2 (en) 2001-06-21 2002-06-21 Atopy

Publications (1)

Publication Number Publication Date
AU2002302851A1 true AU2002302851A1 (en) 2003-01-08

Family

ID=27256198

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002302851A Abandoned AU2002302851A1 (en) 2001-06-21 2002-06-21 Atopy

Country Status (6)

Country Link
US (3) US20050085627A1 (enExample)
EP (1) EP1402031A2 (enExample)
JP (2) JP2005505258A (enExample)
AU (1) AU2002302851A1 (enExample)
CA (1) CA2489623A1 (enExample)
WO (1) WO2003000727A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0115211D0 (en) * 2001-06-21 2001-08-15 Isis Innovation B-cell chronic lymphocytic leukemia
US6979549B2 (en) * 2002-07-16 2005-12-27 Rigel Pharmaceuticals, Inc. Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
WO2005037993A2 (en) 2003-10-06 2005-04-28 Syngenta Participations Ag Promoters functional in plant plastids
US8043596B2 (en) * 2004-09-22 2011-10-25 Showa Denko K.K. Method for producing vapor grown carbon nanotube
US7734423B2 (en) * 2005-09-23 2010-06-08 Crowley Davis Research, Inc. Method, system, and apparatus for virtual modeling of biological tissue with adaptive emergent functionality
US20090070087A1 (en) * 2007-09-07 2009-03-12 Newman Richard D Virtual tissue with emergent behavior and modeling method for producing the tissue
WO2021030271A2 (en) 2019-08-09 2021-02-18 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914335A2 (en) 1996-03-15 1999-05-12 Corixa Corporation Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
JP3521382B2 (ja) * 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
WO1999004265A2 (en) * 1997-07-17 1999-01-28 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
WO1999018210A2 (en) 1997-10-07 1999-04-15 Corixa Corporation Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
ID27813A (id) 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
JP2004507202A (ja) * 1999-03-31 2004-03-11 キュラジェン　コーポレイション ポリペプチドをコードするオープンリーディングフレームを含む核酸；「ｏｒｆｘ」
AU4185100A (en) 1999-04-02 2000-10-23 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
WO2001060860A2 (en) 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use
AU4592601A (en) 2000-03-21 2001-10-03 Millennium Predictive Medicine Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
US20020110815A1 (en) 2000-04-14 2002-08-15 James Lillie Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
CN1329029A (zh) 2000-06-19 2002-01-02 上海博德基因开发有限公司 一种新的多肽——人erg结合蛋白72和编码这种多肽的多核苷酸
WO2002068579A2 (en) 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
CN1376679A (zh) 2001-03-22 2002-10-30 上海博德基因开发有限公司 一种多肽——锚蛋白相似蛋白－77.77和编码这种多肽的多核苷酸
JP2004533227A (ja) 2001-03-29 2004-11-04 インサイト・ゲノミックス・インコーポレイテッド 細胞骨格結合タンパク質
CA2446292A1 (en) 2001-05-04 2003-06-26 Incyte Genomics, Inc. Nucleic acid-associated proteins
US6979549B2 (en) * 2002-07-16 2005-12-27 Rigel Pharmaceuticals, Inc. Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein

Also Published As

Publication number Publication date
JP2005505258A (ja) 2005-02-24
US7364864B2 (en) 2008-04-29
EP1402031A2 (en) 2004-03-31
JP2006081547A (ja) 2006-03-30
WO2003000727A2 (en) 2003-01-03
US20090007280A1 (en) 2009-01-01
US20060257928A1 (en) 2006-11-16
US20050085627A1 (en) 2005-04-21
CA2489623A1 (en) 2003-01-03
WO2003000727A3 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
AU2002337489A1 (en) Inexsufflator
AU2002343482A1 (en) Prolyl-4-hydroxylases
AU2002343483A1 (en) Hydroxypropylamines
AU2002342918A1 (en) 2-guanidino-4-heterocyclylquinazolines
AU2002354285A1 (en) Mini-kraftformer
AU2002302851A1 (en) Atopy
AU2002319532A1 (en) Feeding-bottles
AU2002353397A1 (en) Mini-kraftformer
AU2002330025A1 (en) Atlastin
AU2001100406A4 (en) DriverSMS
AU2002245337A1 (en) Epoxyvibsanin b
AU2002313073A1 (en) Phytocystatin
AU2002339946A1 (en) Maxp1
AU2002257925A1 (en) Numberplates
AU2001100532A4 (en) FonePark
AU2001100522A4 (en) e-Trans
AU2002100746A4 (en) Adrail
AU2001100338A4 (en) Sunglove
AU2001100214A4 (en) Dolly-trolley
AU2002304777A1 (en) Ice-scraper
AU2002325847A1 (en) Bromonitrothienyldioxans
AU2002300980A1 (en) Insanityse
AU2002302413A1 (en) Tryptase-inhibitors
AU2002304686A1 (en) Amidofunctional aminopolydiorganosiloxanes
AU2002300330A1 (en) Spiralnet

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase